Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion‐associated non‐A, non‐B hepatitis
暂无分享,去创建一个
S. Schmolke | E. Tanaka | M. Tacke | K. Hino | K. Kiyosawa | G. Hess | K. Shimoda | A. Engel | A. Engel | K. Kiyosawa | Eiji Tanaka | Kunihiko Hino | Alfred Engel | Georg Hess
[1] P. Marcellin,et al. Influence of Hepatitis G Virus Infection on the Severity of Liver Disease and Response to Interferon- in Patients with Chronic Hepatitis C , 1997, Annals of Internal Medicine.
[2] H. Margolis,et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. , 1997, The New England journal of medicine.
[3] R. Wesley,et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. , 1997, The New England journal of medicine.
[4] M. Hijikata,et al. Characterization of GBV-C/HGV viral genome : comparison among different isolates for a ∼2 kb-sequence that covers entire E1 and most of 5'UTR and E2 , 1997 .
[5] K. Stark,et al. Detection of antibodies to a putative hepatitis G virus envelope protein , 1997, The Lancet.
[6] T. Surowy,et al. An ELISA for detection of antibodies to the E2 protein of GB virus C. , 1997, The Journal of infectious diseases.
[7] M. Manns,et al. Association between fulminant hepatic failure and a strain of GBV virus C , 1996, The Lancet.
[8] T. Pilot‐Matias,et al. Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker. , 1996, Virology.
[9] E. Tanaka,et al. Prevalence and disease association of hepatitis G virus infection in Japan , 1996, Journal of viral hepatitis.
[10] E. Tanaka,et al. Effect of Hepatitis G Virus Infection on Chronic Hepatitis C , 1996, Annals of Internal Medicine.
[11] M. Hijikata,et al. Circulating immune complexes that contain HCV but not GBV-C in co-infected hosts , 1996 .
[12] J. Sheu,et al. A prospective study of transfusion-transmitted GB virus C infection: similar frequency but different clinical presentation compared with hepatitis C virus. , 1996, Blood.
[13] K. Masuko,et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. , 1996, New England Journal of Medicine.
[14] H. Alter. The cloning and clinical implications of HGV and HGBV-C. , 1996, The New England journal of medicine.
[15] H. Margolis,et al. Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent , 1996, Science.
[16] S. Mishiro,et al. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology , 1995, The Lancet.
[17] T. Pilot‐Matias,et al. Isolation of novel virus-like sequences associated with human hepatitis , 1995, Nature Medicine.
[18] D. Bradley,et al. Non-A, Non-B Hepatitis Unrelated to the Hepatitis C Virus (Non-ABC) , 1995, Seminars in liver disease.
[19] R. Purcell,et al. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses , 1994, Journal of virology.
[20] N. Kato,et al. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus , 1993, Journal of virology.
[21] J. Chiba,et al. Clinical significance of antibodies to nonstructural and core proteins of hepatitis C virus in posttransfusion hepatitis patients during long‐term follow‐up , 1993, Journal of medical virology.
[22] G. Nemo,et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. , 1992, The New England journal of medicine.
[23] Giorgio,et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[24] N. Kato,et al. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. , 1992, Virus research.
[25] G. Nemo,et al. HEPATITIS C VIRUS INFECTION IN POST-TRANSFUSION HEPATITIS - AN ANALYSIS WITH FIRST - AND SECOND - GENERATION ASSAYS , 1991 .
[26] Matthew J. Brauer,et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. , 1991, Virology.
[27] R. Purcell,et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. , 1989, The New England journal of medicine.
[28] S. Kwok,et al. Avoiding false positives with PCR , 1989, Nature.
[29] H. Rasmussen. Cellular Calcium Homeostasis and the Calcium Messenger System , 1985, Seminars in liver disease.
[30] C. Keefer. Anemia Associated With Gastrointestinal Disorders: Clinical Considerations and the Value of Iron in Treatment , 1931 .
[31] S. Yagi,et al. Hepatitis G virus/GB virus C infection in patients with chronic non-B, non-C hepatitis , 1997 .
[32] 松本 晶博. Viral and host factors that contribute to efficacy of interferon-α[2a] therapy in patients with chronic hepatitis C , 1995 .
[33] W. Carman. Vaccine-associated Mutants of Hepatitis B Virus , 1994 .